Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Clinical trial NCT02581839 · COMPLETED
Trial details
- NCT number
- NCT02581839
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-17
- Primary completion
- 2018-07-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.